Clinical trial
A Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate Efficacy of OxyjunTM on Cardiac Pumping Capacity as Well as Work Productivity in Individuals With Metabolic Risk
NCT06496880 is registered in ClinicalTrials.gov with Vedic Lifesciences Pvt. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate Efficacy of OxyjunTM on Cardiac Pumping Capacity as Well as Work Productivity in Individuals With Metabolic Risk
- Lead sponsor
- Vedic Lifesciences Pvt. Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 10, 2024
- Completion date
- February 17, 2025
- Enrollment
- 64 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
metabolic disorder